Xu L - Search Results

1

FOXM1 promotes tumor cell invasion and correlates with poor prognosis in early-stage cervical cancer.

He SY, Shen HW, Xu L, Zhao XH, Yuan L, Niu G, You ZS, Yao SZ. He SY, et al. Among authors: xu l. Gynecol Oncol. 2012 Dec;127(3):601-10. doi: 10.1016/j.ygyno.2012.08.036. Epub 2012 Aug 31. Gynecol Oncol. 2012. PMID: 22943878

2

MiR-216b inhibits cell proliferation by targeting FOXM1 in cervical cancer cells and is associated with better prognosis.

He S, Liao B, Deng Y, Su C, Tuo J, Liu J, Yao S, Xu L. He S, et al. Among authors: xu l. BMC Cancer. 2017 Oct 4;17(1):673. doi: 10.1186/s12885-017-3650-5. BMC Cancer. 2017. PMID: 28978307 Free PMC article.

3

Successful management of mucinous ovarian cancer by conservative surgery in week 6 of pregnancy: case report and literature review.

He SY, Shen HW, Xu L, Li XL, Yao SZ. He SY, et al. Among authors: xu l. Arch Gynecol Obstet. 2012 Oct;286(4):989-93. doi: 10.1007/s00404-012-2490-4. Epub 2012 Aug 1. Arch Gynecol Obstet. 2012. PMID: 22850888 Free PMC article. Review.

4

Predictive value of excision repair cross-complementing rodent repair deficiency complementation group 1 and ovarian cancer risk.

He SY, Xu L, Niu G, Ke PQ, Feng MM, Shen HW. He SY, et al. Among authors: xu l. Asian Pac J Cancer Prev. 2012;13(5):1799-802. doi: 10.7314/apjcp.2012.13.5.1799. Asian Pac J Cancer Prev. 2012. PMID: 22901125 Free article. Clinical Trial.

5

Tumor antigen-pulsed CD8α(+) dendritic cells induce T cell-mediated graft-versus-tumor effect in vitro.

Na N, Chen K, Zhang J, He S, Fu Q, Zhu B, Cao K, Xu L. Na N, et al. Among authors: xu l. J Huazhong Univ Sci Technolog Med Sci. 2011 Dec;31(6):728-734. doi: 10.1007/s11596-011-0668-9. Epub 2011 Dec 16. J Huazhong Univ Sci Technolog Med Sci. 2011. PMID: 22173490

6

Screening and identification of significant genes related to tumor metastasis and PSMA in prostate cancer using microarray analysis.

Xu L, Wang Z, Li XF, He X, Guan LL, Tuo JL, Wang Y, Luo Y, Zhong HL, Qiu SP, Cao KY. Xu L, et al. Oncol Rep. 2013 Oct;30(4):1920-8. doi: 10.3892/or.2013.2656. Epub 2013 Aug 5. Oncol Rep. 2013. PMID: 23917490

7

EVI5 is a novel independent prognostic predictor in hepatocellular carcinoma after radical hepatectomy.

Tang J, Ou J, Xu C, Yi C, Xue F, Xu L, Lai F, Tang J, Li S, Kang T, Ding W, Wang B. Tang J, et al. Among authors: xu l, xu c. Oncol Rep. 2017 Oct;38(4):2251-2258. doi: 10.3892/or.2017.5862. Epub 2017 Aug 1. Oncol Rep. 2017. PMID: 28765910

8

Sea cucumber extract TBL-12 inhibits the proliferation, migration, and invasion of human prostate cancer cells through the p38 mitogen-activated protein kinase and intrinsic caspase apoptosis pathway.

Yuan L, Huang X, Zhou K, Zhu X, Huang B, Qiu S, Cao K, Xu L. Yuan L, et al. Among authors: xu l. Prostate. 2019 Jun;79(8):826-839. doi: 10.1002/pros.23788. Epub 2019 Mar 19. Prostate. 2019. PMID: 30889629

9

ZNF488 Enhances the Invasion and Tumorigenesis in Nasopharyngeal Carcinoma Via the Wnt Signaling Pathway Involving Epithelial Mesenchymal Transition.

Zong D, Yin L, Zhong Q, Guo WJ, Xu JH, Jiang N, Lin ZR, Li MZ, Han P, Xu L, He X, Zeng MS. Zong D, et al. Among authors: xu jh, xu l. Cancer Res Treat. 2016 Jan;48(1):334-44. doi: 10.4143/crt.2014.311. Epub 2015 Mar 12. Cancer Res Treat. 2016. PMID: 25779368 Free PMC article.

10

High expression of PSM-E correlated with tumor grade in prostate cancer: a new alternatively spliced variant of prostate-specific membrane antigen.

Cao KY, Mao XP, Wang DH, Xu L, Yuan GQ, Dai SQ, Zheng BJ, Qiu SP. Cao KY, et al. Among authors: xu l. Prostate. 2007 Dec 1;67(16):1791-800. doi: 10.1002/pros.20664. Prostate. 2007. PMID: 17929272

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

42,047 results

Search Page

Filters